Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Long Acting Octreotide in Idiopathic Pulmonary Fibrosis

NCT00463983 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT00463983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00463983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Long Acting Octreotide in Idiopathic Pulmonary Fibrosis
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2006
Completion date
January 31, 2012
Enrollment
25 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis